Skip to main content

Identifying a Shared Metabolomic Signature in Mother-Newborn Dyads With and Without Gestational Diabetes: Implications for Early Metabolic Programming

In brief

Maternal-newborn metabolite patterns persist in gestational diabetes, with two amino acids added

In 112 mother-newborn pairs, researchers found a shared profile involving arginine, methionine, acetylcarnitine and free carnitine that was strongly correlated between mothers and newborns and present with or without gestational diabetes. Valine and alanine contributed only to the profile in diabetes-exposed pairs; whether these differences affect later health remains unknown.

Journal
International journal of molecular sciences (Q1)
Published
31 October 2026
Study design
Cross-sectional study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Isabel Omaña-Guzmán, Juan Carlos López-Alvarenga, Berenice Palacios-González, Fernanda Jaramillo-Pimentel, Luis Lanz-Pérez, Amhed Alvarado-González, et al.
PMID
43028033
DOI
10.3390/ijms27219786

Why clinicians should know about it

  • Picked for Embryology (top studies of the week, 15 November 2026): Maternal metabolic exposure and fetal developmental programming

Abstract

Pregnancy is a critical window for metabolic programming, during which adverse intrauterine exposures may influence long-term health. GDM alters the intrauterine environment, but its role in early metabolic programming remains poorly understood. Thus, the objective of this study was to identify the shared metabolomic signature in mother-newborn dyads and to assess whether GDM modifies this signature. For this purpose, we conducted a cross-sectional study including mother-newborn dyads recruited at the General Hospital of Mexico. Blood samples were collected from dyads. Amino acids and acylcarnitines were quantified by tandem mass spectrometry. Sparse partial least squares (sPLS) analysis was used to identify shared metabolomic signatures within mother-newborn dyads. Linear mixed-effects models evaluated the modifying effect of GDM on shared metabolites. A total of 112 mother-newborn dyads (68 without GDM and 44 with GDM) were included. Two shared metabolomic signatures were identified. The first, characterized by arginine, methionine, acetylcarnitine, and free carnitine, showed a strong maternal-newborn correlation. Although this core signature was preserved in both groups, valine and alanine contributed exclusively to the GDM-exposed dyads. In conclusion, a shared metabolomic signature related to fetal development and energy metabolism was conserved regardless of GDM status, although GDM partially modified this signature. These findings provide insights into metabolic processes potentially involved in early metabolic programming.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.